Insider Transactions in Q3 2025 at Avidity Biosciences, Inc. (RNA)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2025
|
Steven George Hughes Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,542
-3.82%
|
$69,390
$45.41 P/Share
|
|
Sep 15
2025
|
Steven George Hughes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,542
+3.68%
|
$9,252
$6.57 P/Share
|
|
Sep 15
2025
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
15,000
-13.38%
|
$615,000
$41.41 P/Share
|
|
Sep 15
2025
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+11.8%
|
$330,000
$22.34 P/Share
|
|
Sep 11
2025
|
W. Michael Flanagan Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
20,000
-19.96%
|
$760,000
$38.94 P/Share
|
|
Sep 11
2025
|
W. Michael Flanagan Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+16.64%
|
$280,000
$14.22 P/Share
|
|
Sep 05
2025
|
Troy Edward Wilson Director |
SELL
Open market or private sale
|
Direct |
29,500
-19.44%
|
$1,475,000
$50.0 P/Share
|
|
Sep 05
2025
|
Troy Edward Wilson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,500
+14.73%
|
$174,000
$12.48 P/Share
|
|
Sep 05
2025
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-14.05%
|
$2,450,000
$49.95 P/Share
|
|
Sep 05
2025
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+12.32%
|
$50,000
$1.24 P/Share
|
|
Sep 03
2025
|
Eric Mosbrooker Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
6,563
-10.66%
|
$308,461
$47.07 P/Share
|
|
Sep 03
2025
|
Eric Mosbrooker Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,563
+9.63%
|
$59,067
$9.05 P/Share
|
|
Sep 02
2025
|
Kathleen P. Gallagher Chief Program Officer |
SELL
Open market or private sale
|
Direct |
188
-0.37%
|
$8,836
$47.42 P/Share
|
|
Aug 28
2025
|
Sarah Boyce President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-7.56%
|
$1,225,000
$49.39 P/Share
|
|
Aug 28
2025
|
Sarah Boyce President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+7.03%
|
$25,000
$1.24 P/Share
|
|
Aug 22
2025
|
Steven George Hughes Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,208
-5.38%
|
$101,568
$46.4 P/Share
|
|
Aug 22
2025
|
Steven George Hughes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,208
+5.1%
|
$22,080
$10.16 P/Share
|
|
Aug 15
2025
|
Teresa Mc Carthy Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
10,000
-9.33%
|
$460,000
$46.56 P/Share
|
|
Aug 15
2025
|
Teresa Mc Carthy Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+8.54%
|
$220,000
$22.34 P/Share
|
|
Aug 13
2025
|
Steven George Hughes Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,542
-3.82%
|
$70,932
$46.66 P/Share
|
|
Aug 13
2025
|
Steven George Hughes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,542
+3.68%
|
$9,252
$6.57 P/Share
|
|
Aug 06
2025
|
Michael F Mac Lean Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
30,914
-31.96%
|
$1,298,388
$42.73 P/Share
|
|
Aug 06
2025
|
Eric Mosbrooker Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
130,807
-38.56%
|
$5,755,508
$44.06 P/Share
|
|
Aug 06
2025
|
Eric Mosbrooker Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
124,687
+40.16%
|
$1,122,183
$9.05 P/Share
|
|
Aug 06
2025
|
Arthur A Levin Director |
SELL
Open market or private sale
|
Direct |
107,500
-84.55%
|
$5,052,500
$47.62 P/Share
|
|
Aug 06
2025
|
Arthur A Levin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
107,500
+45.81%
|
$2,365,000
$22.34 P/Share
|
|
Aug 06
2025
|
Troy Edward Wilson Director |
SELL
Open market or private sale
|
Indirect |
65,554
-27.5%
|
$2,949,930
$45.0 P/Share
|
|
Aug 06
2025
|
Troy Edward Wilson Director |
SELL
Open market or private sale
|
Direct |
29,500
-16.91%
|
$1,327,500
$45.0 P/Share
|
|
Aug 06
2025
|
Troy Edward Wilson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,500
+14.14%
|
$354,000
$12.26 P/Share
|
|
Aug 06
2025
|
Steven George Hughes Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
81,434
-20.37%
|
$3,420,228
$42.74 P/Share
|
|
Aug 06
2025
|
Steven George Hughes Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
47,451
+12.01%
|
$616,863
$13.79 P/Share
|
|
Aug 04
2025
|
John B Moriarty Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,245
-4.49%
|
$80,820
$36.21 P/Share
|